Company Filing History:
Years Active: 2021
Title: Elisabeth Therese Jeanne Pasquter: Innovator in Pharmaceutical Chemistry
Introduction
Elisabeth Therese Jeanne Pasquter is a notable inventor based in Issy-les-Moulineaux, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that serve as inhibitors for specific biological pathways.
Latest Patents
Pasquter holds a patent for "Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors." This invention relates to bicyclic derivatives of Formula (I), which are defined in the claims. The compounds developed by Pasquter are recognized for their utility as PI3Kβ inhibitors. Furthermore, the invention encompasses pharmaceutical compositions that include these compounds as active ingredients, highlighting their potential use as medicaments.
Career Highlights
Elisabeth Pasquter is associated with Janssen Pharmaceutica NV, a prominent company in the pharmaceutical industry. Her work focuses on innovative solutions that address critical health challenges through the development of new therapeutic agents.
Collaborations
Pasquter has collaborated with esteemed colleagues, including Didier Jean-Claude Berthelot and Laurence Anne Mevellec. These partnerships have contributed to the advancement of her research and the successful development of her patented compounds.
Conclusion
Elisabeth Therese Jeanne Pasquter exemplifies the spirit of innovation in pharmaceutical chemistry. Her work on PI3K beta inhibitors showcases her commitment to advancing medical science and improving patient outcomes.